RegisTICs: Adult Tic Disorders Registry

Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Not yet recruiting ID

Study Details

Study Description

Brief Summary

The purpose of this study is to develop the adult tic disorders registry in order to characterize the relationship between tic severity and tic-related impairment in women compared to men with tic disorders.

Condition or Disease Intervention/Treatment Phase
  • Other: QOL to be completed by the participant

Study Design

Study Type:
Anticipated Enrollment :
100 participants
Observational Model:
Time Perspective:
Official Title:
Adult Tic Disorders Registry
Anticipated Study Start Date :
Oct 15, 2021
Anticipated Primary Completion Date :
Oct 15, 2023
Anticipated Study Completion Date :
Oct 15, 2023

Arms and Interventions

Arm Intervention/Treatment
Quality of life questionnaires

Other: QOL to be completed by the participant
The scales (PUTS, OCI, TS-QOL, ASRS, GAD-7, PHQ9, TAPS) to be completed by the participant

Outcome Measures

Primary Outcome Measures

  1. Correlation between Quality of Life and TICs severity [6 months]

    Severity of the tics measurement (YGTSS Impairment Score) and the quality of life (TS-QOL) between men and women with tic disorders, while controlling for the YGTSS Total Tic Score

Secondary Outcome Measures

  1. Change in TICs [6 months]

    Change in tic inventories/tic migrations with the YGTSS tic inventories

Eligibility Criteria


Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Inclusion criteria :
  1. Age >18 years

  2. Patients with Tic disorders

  3. Given the non-opposition

Non Inclusion criteria

  1. No affiliation to a French health social insurance

  2. Significant congenital disorders that may affect understanding of assessments

  3. Patients under guardianship or curatorship

Contacts and Locations


No locations specified.

Sponsors and Collaborators

  • Assistance Publique - Hôpitaux de Paris


None specified.

Study Documents (Full-Text)

None provided.

More Information


None provided.
Responsible Party:
Assistance Publique - Hôpitaux de Paris Identifier:
Other Study ID Numbers:
  • APHP210801
First Posted:
Oct 25, 2021
Last Update Posted:
Oct 25, 2021
Last Verified:
Sep 1, 2021
Studies a U.S. FDA-regulated Drug Product:
Studies a U.S. FDA-regulated Device Product:
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 25, 2021